White Plains, NYNCT07365319Now EnrollingIRB Ready

Non Small Cell Lung Cancer (Squamous or Non Squamous) Clinical Trial in White Plains, NY

Access cutting-edge non small cell lung cancer (squamous or non squamous) treatment through this clinical trial at a research site in White Plains. Study-provided care at no cost to qualified participants.

Sponsored by Eikon Therapeutics

Quick Self-Assessment

See if you qualify for this White Plains location

Preparing your pre-screening questions…

Expert Care in White Plains

Access non small cell lung cancer (squamous or non squamous) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non small cell lung cancer (squamous or non squamous) treatment provided free

Apply for This White Plains Location

Check if you qualify for this non small cell lung cancer (squamous or non squamous) clinical trial in White Plains, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to White Plains

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit White Plains site if eligible
  4. 4Begin participation

About This Non Small Cell Lung Cancer (Squamous or Non Squamous) Study in White Plains

This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chemotherapy for patients with stage 4 NSCLC.

Sponsor: Eikon Therapeutics

Who Can Participate

Inclusion Criteria

Participant must be ≥ 18 years old at the time of signing the informed consent.
Participant has a life expectancy of at least 3 months.
Participant has histologically or cytologically confirmed Stage 4 NSCLC predominately squamous or non-squamous) and is considered a candidate for standard therapy with pembrolizumab and chemotherapy. Participants with NSCLC-NOS (not otherwise specified) will be considered as non-squamous NSCLC.
Participant must have documented evidence that mutation-directed therapy is not indicated, based on the absence of tumor-activating mutations or fusions (e.g., but not limited to EGFR, ALK, RET, ROS1, BRAF) for which approved first-line targeted therapies are available to the participant in their respective country.
Participant has at least 1 lesion with measurable disease at Baseline according to RECIST 1.1 as determined locally. Lesions situated in a previously irradiated area are considered measurable if progression has been shown in such lesions.
Participant has not received prior systemic therapy for advanced/metastatic NSCLC. Note: Participants who received adjuvant or neoadjuvant treatment (after surgery and/or radiation therapy) and developed recurrent or metastatic disease more than 1 year after completing therapy are eligible.
Participant has an ECOG Performance Status of 0 to 1 assessed no more than 10 days before start of the treatment.
Participant has tumor tissue available for PD-L1 testing from a site that was not radiated prior to biopsy, and was obtained, ideally, after diagnosis of metastatic disease. Biopsies obtained prior to receipt of adjuvant/neoadjuvant chemotherapy will be permitted if recent biopsy is not feasible (provided the specimen is \< 3yrs old). Key

Exclusion Criteria

has small cell elements present histologically and/or the tumors are not predominantly non-squamous or squamous NSCLC.
is currently actively enrolled in or has recently participated in a study of an investigational agent and received investigational therapy within 4 weeks or 5 half-lives (whichever is longer) of administration of EIK1001 or placebo.
has had major surgery (\< 3 weeks prior to the first dose of study intervention administration).
has received a live-virus vaccination within 30 days of the start of study intervention initiation.
has received radiation therapy within 7 days of the first dose of study intervention administration.
has completed palliative radiotherapy within 7 days of the first dose of study intervention administration.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in White Plains?

Yes, this clinical trial (NCT07365319) has an active research site in White Plains, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non Small Cell Lung Cancer (Squamous or Non Squamous) Treatment Options in White Plains, NY

If you're searching for non small cell lung cancer (squamous or non squamous) treatment options in White Plains, NY, this clinical trial (NCT07365319) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our White Plains research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non small cell lung cancer (squamous or non squamous) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non small cell lung cancer (squamous or non squamous) clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in White Plains, NY

See all lung cancer clinical trials recruiting in White Plains — not just this study.

Browse Lung Cancer Trials in White Plains →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in White Plains?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · White Plains, NY